Cell and Gene Therapy

Kalorama Information’s latest report, Autoimmune Immunoassay Market Opportunities, 2021-2026, delves into the expansive and evolving landscape of diagnostic tests for autoimmune diseases. As the market for autoimmune diagnostics continues to grow, substantial opportunities for innovation and advancement emerge. This report provides a comprehensive analysis of current and future market prospects, highlighting the potential for revenue…

Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, and expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge investments in R&D. Globally,…

Contract manufacturing is becoming increasingly vital in the pharmaceutical industry, particularly in cell and gene therapy due to the high demand for these innovative products. Kalorama Information’s report, Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs), provides comprehensive insights into this dynamic market.

Report Highlights:

• Biopharmaceutical Contract Manufacturing Market: In-depth analysis of…

What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…